Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Posted on by ScienceFather

Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Dr Omid Yeganeh, Islamic Azad University, Iran

Dr. Omid Yeganeh is a microbiologist with a Ph.D. in Microbiology from the Islamic Azad University, Tehran, Iran. He also holds an M.Sc. in Microbiology and a B.Sc. in Cellular and Molecular Biology. As a researcher at the Monoclonal Antibody Research Center, Avicenna Research Institute, he specializes in producing monoclonal antibodies against various molecules, including PSA, prolactin, ferritin, and sperm surface antigens. Dr. Yeganeh serves as a technical editor and associate editor for several journals, contributing to the advancement of microbiological research. His work has significantly impacted the field of immunology and antibody development. 🔬🧬💉

Publication profile

google scholar

Education

Dr. Omid Yeganeh holds an impressive academic background, earning a Ph.D. in Microbiology from the Department of Microbiology at the Islamic Azad University, Tehran, Iran. His M.Sc. in Microbiology and B.Sc. in Cellular and Molecular Biology with a focus on Microbiology further enhance his foundational knowledge in the field. As a member of the Monoclonal Antibody Research Center at the Avicenna Research Institute, he is well-versed in cutting-edge research methodologies.

Research Experience

Dr. Yeganeh’s extensive experience as a researcher at the Monoclonal Antibody Research Center showcases his commitment to advancing the field of microbiology and immunology. His role as a technical editor and associate editor for scientific journals highlights his expertise and active participation in academic discourse. His hands-on research experience equips him with a practical understanding of the latest methodologies in microbiology.

Research Activities

His work focuses on the production of monoclonal antibodies against various clinically significant molecules, including PSA, prolactin, and sperm surface antigens. He has successfully produced monoclonal antibodies against over 100 different peptides, showcasing his technical expertise in hybridoma techniques and cell culture. This innovative research has the potential to contribute significantly to diagnostic and therapeutic applications in medicine.

Congress Participation

Dr. Yeganeh actively participates in international congresses, such as the 15th Virtual International Congress of Immunology & Allergy and the ICIA 2023, where he presents his research findings. His engagement in these forums not only broadens his professional network but also enhances the visibility of his research contributions on a global scale.

Research focus

Dr. Omid Yeganeh is a prominent researcher with a focus on medical biotechnology, particularly in immunology and microbiology. His work includes the production and characterization of monoclonal antibodies against various human proteins and pathogens, highlighting his expertise in antibody development for diagnostic and therapeutic applications. He has also investigated infectious diseases, including the emergence of antibiotic-resistant bacteria, contributing to the understanding of microbial drug resistance. His research significantly impacts both clinical diagnostics and therapeutic strategies. 🧬🔬📊

Publication top notes

Intra-and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction …

The Challenge of Global Emergence of Novel Colistin-Resistant Escherichia coli ST131

Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta‐specific 1

A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of Labbafinejad …

Production and characterization of a murine monoclonal antibody against human ferritin

Skull base aneurysmal bone cyst presented with foramen jugular syndrome and multi-osseous involvement

Fibro-osseous lesions of the skull base in the pediatric population

Production and characterization of monoclonal antibodies against human prostate specific antigen

Conclusion

Dr. Omid Yeganeh’s academic credentials, research experience, and extensive publication record make him a highly suitable candidate for the Best Researcher Award. His innovative research in monoclonal antibody production and his commitment to advancing scientific knowledge in microbiology not only demonstrate his capabilities as a researcher but also indicate his potential for future contributions to the field.

 

Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Posted on by ScienceFather

Prof. Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Prof. Ammu Kutty Radhakrishnan, Monash University Malaysia, Malaysia

 

Prof. Ammu Kutty Radhakrishnan is a distinguished immunologist with a PhD from the University of Cambridge (1994), an MSc in Biochemistry (1990), and a BSc (First Class Honours) from the University of Malaya (1987). Currently, a Professor of Immunology at Monash University Malaysia, she has over 25 years of academic leadership and research experience. Prof. Ammu specializes in immunotherapy and food as medicine research, serving as Head of this research strength. Her career spans significant roles at International Medical University and Oxford. She is a research consultant, active in COVID-19 vaccine efforts, and supervises PhD and MSc students. 🌿🧬📚

 

Publication Profile

Google Scholar

Academic Excellence

Prof. Ammu Kutty Radhakrishnan has an exceptional academic background, with a PhD in Immunology from the University of Cambridge (1994) and degrees in Biochemistry from the University of Malaya. Her education forms a solid foundation for her expertise in immunology and biomedical sciences, contributing to her distinguished career.

Professional Experience

Prof. Radhakrishnan has held key roles, such as Professor at Monash University Malaysia and the International Medical University (IMU). Her leadership in academic programs, such as head of the Food as Medicine Research Strength and chief examiner roles, showcases her commitment to advancing education and research.

Research Contributions

Prof. Radhakrishnan has supervised numerous PhD and Master’s students, guiding 39 doctoral and 20 master’s research projects to completion. Her extensive research supervision experience highlights her dedication to fostering scientific inquiry and innovation. Additionally, her collaborative efforts with industry partners demonstrate her ability to apply research to real-world problems.

Conclusion

Prof. Ammu Kutty Radhakrishnan’s outstanding academic credentials, extensive research supervision, leadership roles, and global health contributions, she is an ideal candidate for the Best Researcher Award. Her work in immunology, biomedicine, and collaboration with industry partners demonstrates her excellence in both academic and applied research, making her a worthy contender for this prestigious recognition.

 

Publication Top Notes  

  • Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals (2010) – 292 citations 🧪
  • Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59 (1994) – 259 citations 🧬
  • Rind of the rambutan, Nephelium lappaceum, a potential source of natural antioxidants (2008) – 193 citations 🍇
  • Current concepts of neurodegenerative mechanisms in Alzheimer’s disease (2018) – 176 citations 🧠
  • Bioactive Compounds: Natural Defense Against Cancer? (2019) – 169 citations 🌿
  • Protective mechanisms of flavonoids in Parkinson’s disease (2015) – 162 citations 🧑‍⚕️
  • Tocotrienol research: past into present (2012) – 157 citations 🌰
  • Standardised Mangifera indica extract is an ideal antioxidant (2009) – 149 citations 🥭
  • Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson’s disease (2020) – 128 citations 🚀
  • Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice (2004) – 126 citations 🧫
  • Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity (2013) – 124 citations 🧪

 

Rushna Wazahat | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Rushna Wazahat | Immunology and Microbiology | Best Researcher Award

Mrs Rushna Wazahat, Jamia Hamdard, India

Based on the provided details, Mrs. Rushna Wazahat is a strong candidate for the Best Researcher Award. Her academic background, extensive research experience, and significant contributions to the field of medical microbiology, particularly in tuberculosis diagnosis, make her highly suitable for this award.

Publication profile

google scholar

Education

Mrs. Rushna Wazahat has a robust educational foundation, beginning with a B.Sc. in Botany (Hons.) from Ramjas College, University of Delhi, followed by an M.Sc. in Medical Microbiology from HIMSR, Jamia Hamdard. Her thesis work on the efficacy of diagnostic tools for tuberculosis showcases her early commitment to impactful research. Currently, she is pursuing a Ph.D. at Jamia Hamdard, focusing on novel biomarkers for tuberculosis diagnosis, which underlines her dedication to advancing medical science.

Research & Teaching

With experience as a Junior Research Scientist at Valetude Primus Healthcare and a Tutor/Demonstrator at SGT Medical College, Mrs. Wazahat has gained valuable hands-on experience. Her role as a Research Assistant in a DBT project on innate immunity during Mycobacterium tuberculosis infection further highlights her research acumen. Her ongoing Ph.D. research in the Department of Biochemistry at Jamia Hamdard continues to build on her expertise in tuberculosis research.

Publications

Mrs. Wazahat has published several impactful research papers in reputable journals. Her work spans various aspects of tuberculosis research, including diagnostic methods and epigenetic regulations in Mycobacterium tuberculosis infection. These publications, such as her contributions to the Indian Journal of Tuberculosis and Journal of Microbiological Methods, demonstrate her significant contributions to the field and her ability to communicate complex research effectively.

Seminars & Workshops

Her active participation in international conferences, such as the 2023 International Annual Conference on Medicine and Surgery, and various workshops on scientific writing, ethics, and hospital infection control, reflects her commitment to continuous learning and knowledge dissemination. These engagements not only enhance her own expertise but also contribute to the broader scientific community.

Poster Presentations

Mrs. Wazahat has a strong track record in poster presentations, having won several awards, including the Best Poster Award at the 6th International Leh Symposium 2022. Her success in innovation categories and other competitive events highlights her creativity and ability to present research compellingly.

Extra-Curricular Activities

Her involvement in volunteer work and participation in extracurricular activities, such as calligraphy and leaf mosaic contests, demonstrates her well-rounded personality and commitment to community engagement.

Conclusion

In conclusion, Mrs. Rushna Wazahat’s extensive academic background, impactful research, and active participation in scientific discourse make her an exemplary candidate for the Best Researcher Award. Her work has significant implications for tuberculosis diagnosis and treatment, making her a valuable asset to the scientific community.

Publication top notes

Antimicrobial susceptibility patterns of an emerging multidrug resistant nosocomial pathogen: Acinetobacter baumannii

A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria

Epigenetic regulations in Mycobacterium tuberculosis infection

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting

Strategic Diagnosis-Unraveling Tuberculosis-A comprehensive Approach

96well-formatted CrfA assay for differentiation of Mycobacterium tuberculosis and Non-tuberculous mycobacteria

Structural basis for the role of C-terminus acidic tail of Saccharomyces cerevisiae ubiquitin-conjugating enzyme (Rad6) in E3 ligase (Bre1) mediated recognition of histones

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting